(Q35230478)

7 August 2017

1 reference

title

Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates (English)

1 reference

7 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1321576

13 September 2022

reinforcement

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1321576

13 September 2022

author name string

Bals-Kubik R

4

1 reference

7 August 2017

T. S. Shippenberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1321576

13 September 2022

A. Herz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1321576

13 September 2022

R. Spanagel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1321576

13 September 2022

R. Bals-Kubik

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1321576

13 September 2022

C. Stein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1321576

13 September 2022

language of work or name

English

0 references

publication date

1 June 1992

1 reference

7 August 2017

28 June 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1321576

Annals of the New York Academy of Sciences

13 September 2022

published in

1 reference

7 August 2017

654

1 reference

7 August 2017

347-356

1 reference

The use of place conditioning in studying the neuropharmacology of drug reinforcement.

7 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Fentanyl isothiocyanate reveals the existence of physically associated mu- and delta-opioid receptors mediating inhibition of adenylate cyclase in rat neostriatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Heroin reward is dependent on a dopaminergic substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Drug-induced place preference in rats with 5,7-dihydroxytryptamine lesions of the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Circling from intracranial morphine applied to the ventral tegmental area in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Selectivity of various opioid peptides towards delta-, kappa; and mu-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB25980.X

10.1111/J.1749-6632.1992.TB25980.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference